Answers are grounded in this paper and cite their sources.
A combined mass spectrometry and bioinformatics screening technique has been developed for detecting the administration of exogenous growth hormone (GH), through changes in the serum proteome. Serum samples from porcine GH (n=14) and placebo (n=13) treated mice were analysed by MALDI-TOF-MS. Mass spectrometric data were processed using artificial neural networks to identify protein biomarkers capable of differentiating between control and GH treated subjects. Four ions m/z 17201 (± 34), 18978 (± 38), 19860 (± 40) and 20190 (± 40) were identified, which correctly predicted 93 % of a separate subset of blind samples. The sensitivity and specificity of the model was respectively 86 % and 100 % (12/14 GH treated and 13/13 controls correctly assigned respectively). Reproducibility of the four ion model was assessed using an intra-laboratory replicate data set of separately prepared serum samples. Our results show the potential of MALDI-MS for detecting GH administration with good sensitivity and specificity through indicative biomarker patterns determined using computational bioinformatics techniques.
No takes yet. Share an insight, caveat, or question.
A 2007 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: